COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 278.8 | 1 | 0229-0438 | 720.28 | 437.38 | 302 | 67.60 | 0.831 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 1887.4 | 1 | 0230-0439 | 18.11 | 439.59 | 340 | 68.43 | 0.913 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 233.1 | 1 | 0231-0441 | 169.96 | 442.00 | 318 | 66.18 | 0.912 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 1131.3 | 1 | 0232-0444 | 771.12 | 444.45 | 230 | 57.36 | 0.879 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 354.4 | 1 | 0233-0447 | 477.66 | 447.79 | 262 | 61.36 | 0.875 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 2130.1 | 1 | 0234-0456 | 438.10 | 457.77 | 540 | 95.40 | 0.746 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 408.7 | 1 | 0235-0456 | 881.35 | 455.43 | 335 | 78.57 | 0.682 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 1375.1 | 1 | 0236-0456 | 265.11 | 456.45 | 313 | 65.60 | 0.914 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 1619.7 | 1 | 0237-0460 | 511.98 | 459.79 | 454 | 81.26 | 0.864 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 4875.3 | 1 | 0238-0456 | 409.18 | 456.62 | 214 | 53.36 | 0.945 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 683.5 | 1 | 0239-0461 | 38.50 | 461.65 | 307 | 66.18 | 0.881 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 620.9 | 1 | 0240-0462 | 165.64 | 462.71 | 309 | 71.60 | 0.757 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 1849.8 | 1 | 0241-0468 | 330.38 | 467.02 | 250 | 58.77 | 0.910 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 1139.1 | 1 | 0242-0470 | 569.44 | 470.56 | 357 | 69.84 | 0.920 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 661.6 | 1 | 0243-0470 | 930.07 | 470.50 | 260 | 59.36 | 0.927 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 293.2 | 1 | 0244-0471 | 789.81 | 471.64 | 322 | 67.01 | 0.901 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 5406.1 | 1 | 0245-0474 | 229.06 | 473.77 | 379 | 73.26 | 0.888 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 2269.6 | 1 | 0246-0471 | 387.85 | 471.68 | 248 | 58.77 | 0.902 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 553.7 | 1 | 0247-0472 | 706.29 | 472.14 | 277 | 63.11 | 0.874 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 2725.3 | 1 | 0248-0481 | 321.87 | 481.24 | 242 | 58.77 | 0.880 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 2322.0 | 1 | 0249-0485 | 380.17 | 485.37 | 224 | 55.94 | 0.899 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 506.2 | 1 | 0250-0486 | 625.83 | 486.05 | 324 | 66.18 | 0.930 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 267.4 | 1 | 0251-0487 | 260.40 | 486.47 | 279 | 63.01 | 0.883 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 2748.6 | 1 | 0252-0488 | 501.49 | 489.01 | 313 | 66.77 | 0.882 |
COLO 858 | Vemurafenib | 0.0316 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 274.9 | 1 | 0253-0492 | 911.58 | 492.21 | 260 | 59.70 | 0.917 |